DK3894410T3 - Substituerede xanthinderivater - Google Patents

Substituerede xanthinderivater Download PDF

Info

Publication number
DK3894410T3
DK3894410T3 DK19820718.5T DK19820718T DK3894410T3 DK 3894410 T3 DK3894410 T3 DK 3894410T3 DK 19820718 T DK19820718 T DK 19820718T DK 3894410 T3 DK3894410 T3 DK 3894410T3
Authority
DK
Denmark
Prior art keywords
xanthind
derivatives
substituted
xanthind derivatives
substituted xanthind
Prior art date
Application number
DK19820718.5T
Other languages
English (en)
Inventor
Kai Gerlach
Original Assignee
Boehringer Ingelheim Int
Hydra Biosciences Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int, Hydra Biosciences Llc filed Critical Boehringer Ingelheim Int
Application granted granted Critical
Publication of DK3894410T3 publication Critical patent/DK3894410T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK19820718.5T 2018-12-12 2019-12-10 Substituerede xanthinderivater DK3894410T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18212060 2018-12-12
PCT/EP2019/084375 WO2020120450A1 (en) 2018-12-12 2019-12-10 Substituted xanthine derivatives

Publications (1)

Publication Number Publication Date
DK3894410T3 true DK3894410T3 (da) 2023-11-27

Family

ID=64665184

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19820718.5T DK3894410T3 (da) 2018-12-12 2019-12-10 Substituerede xanthinderivater

Country Status (18)

Country Link
US (2) US11198696B2 (da)
EP (1) EP3894410B1 (da)
JP (1) JP2022512373A (da)
KR (1) KR20210102955A (da)
CN (1) CN113166151B (da)
AU (1) AU2019396499A1 (da)
BR (1) BR112021008316A2 (da)
CA (1) CA3119229A1 (da)
CL (1) CL2021001509A1 (da)
DK (1) DK3894410T3 (da)
EA (1) EA202191588A1 (da)
ES (1) ES2964630T3 (da)
HU (1) HUE064908T2 (da)
IL (1) IL283768B2 (da)
MX (1) MX2021007019A (da)
PL (1) PL3894410T3 (da)
TW (1) TWI825243B (da)
WO (1) WO2020120450A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3119229A1 (en) * 2018-12-12 2020-06-18 Boehringer Ingelheim International Gmbh Substituted xanthine derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2970303T1 (sl) * 2013-03-15 2017-08-31 Hydra Biosciences, Inc. Substituirani ksantini in njihove metode uporabe
GB201702160D0 (en) 2017-02-09 2017-03-29 Univ Leeds Innovations Ltd Inhibitors for use in therapy
ES2903268T3 (es) * 2017-07-11 2022-03-31 Boehringer Ingelheim Int Derivados de xantina sustituida
CA3119229A1 (en) * 2018-12-12 2020-06-18 Boehringer Ingelheim International Gmbh Substituted xanthine derivatives

Also Published As

Publication number Publication date
TWI825243B (zh) 2023-12-11
AU2019396499A1 (en) 2021-05-27
MX2021007019A (es) 2021-09-10
TW202039495A (zh) 2020-11-01
BR112021008316A2 (pt) 2021-08-03
CL2021001509A1 (es) 2021-12-17
CN113166151B (zh) 2023-12-01
EP3894410B1 (en) 2023-10-11
IL283768A (en) 2021-07-29
WO2020120450A1 (en) 2020-06-18
IL283768B2 (en) 2024-05-01
US20220177479A1 (en) 2022-06-09
US20200190093A1 (en) 2020-06-18
EP3894410A1 (en) 2021-10-20
IL283768B1 (en) 2024-01-01
US11198696B2 (en) 2021-12-14
CN113166151A (zh) 2021-07-23
EA202191588A1 (ru) 2021-10-18
JP2022512373A (ja) 2022-02-03
PL3894410T3 (pl) 2024-03-18
ES2964630T3 (es) 2024-04-08
KR20210102955A (ko) 2021-08-20
HUE064908T2 (hu) 2024-04-28
CA3119229A1 (en) 2020-06-18

Similar Documents

Publication Publication Date Title
DK3810587T3 (da) Substituerede alkoxypyridinylindolsulfonamider
DK3768669T3 (da) Piperazinazaspiroderivater
DK3823970T3 (da) Yderligere substituerede triazoloquinoxalinderivater
DK3823971T3 (da) Substituerede triazol-quinoxalin-derivater
DK3796975T3 (da) Sulfonylaminobenzamidderivater
DK3645513T3 (da) Benzazepinderivater
DK3642202T3 (da) Dihydro-pyrrolo-pyridin-derivater
DK3894410T3 (da) Substituerede xanthinderivater
DK3770162T3 (da) Dihydrochromenderivater
DK3752258T3 (da) Trampolin
DK3587968T3 (da) Fluidsystem
MA49925A (fr) Claie
DE112019000442A5 (de) Ringtilgereinrichtung
NO20181678A1 (no) Rissanviser
JP1628555S (ja) たい焼
JP1628556S (ja) たい焼
ES1218724Y (es) Terrario
ES1224156Y (es) Ecobolsera
UA38627S (uk) Пневмофарбопульт
UA38606S (uk) Електролобзик
UA38633S (uk) Електролобзик
UA38598S (uk) Пневмофарбопульт
UA38585S (uk) Електролобзик
UA38632S (uk) Електролобзик
UA38602S (uk) Термокухоль